Monday 21 September 2020
Home      All news      Contact us      English
eaglenews - 2 month ago

Novavax reports promising early trial results of COVID-19 vaccine

WASHINGTON, United States (AFP) US biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial. The company was given $1.6 billion by the US government last month to develop and fund the drug under Operation Warp Speed but in terms of timeline it is behind other firms including Moderna and [ ]


Latest News
Hashtags:   

Novavax

 | 

reports

 | 

promising

 | 

early

 | 

trial

 | 

results

 | 

COVID

 | 

vaccine

 | 

Sources